参考文献/References:
[1] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545.
[2] Alkhawam H,Zaiem F,Sogomonian R,et al. Coronary artery disease in young adults[J]. Am J Med Sci,2015,350(6):479-483.
[3] Thériault S,Lali R,Chong M,et al. Polygenic contribution in individuals with early-onset coronary artery disease[J]. Circ Genom Precis Med,2018,11(1):e001849.
[4] Abd El-Aziz TA,Hussein YM,Mohamed RH,et al. Renin-angiotensin system genes polymorphism in Egyptians with premature coronary artery disease[J]. Gene,2012,498(2):270-275.
[5]Azova M,Timizheva K,Ait Aissa A,et al. Gene polymorphisms of the renin-angiotensin-aldosterone system as risk factors for the development of in-stent restenosis in patients with stable coronary artery disease[J]. Biomolecules,2021,11(5):763.
[6] Zhu B,Si X,Gong Y,et al. An association between the endothelial nitric oxide synthase gene G894T polymorphism and premature coronary artery disease:a meta-analysis[J]. Oncotarget,2017,8(44): 77990-77998.
[7] Zigra AM,Rallidis LS,Anastasiou G,et al. eNOS gene variants and the risk of premature myocardial infarction[J]. Dis Markers,2013,34(6):431-436.
[8] Erdmann J,Stark K,Esslinger UB,et al. Dysfunctional nitric oxide signalling increases risk of myocardial infarction[J]. Nature,2013,504(7480):432-436.
[9] Shan H,Zhang M,Zhang M,et al. Association of rs5368 and rs3917406 polymorphisms in E-selectin gene with premature coronary artery disease in Chinese Han population[J]. Int J Clin Exp Med,2015,8(3):4387-4392.
[10] Sun J,Han W,Wu S,et al. Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults≤35?years of age[J]. BMC Cardiovasc Disord,2021,21(1):47.
[11] Hou X,Chen X,Shi J. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility:a meta-analysis[J]. Gene,2015,565(1):39-44.
[12] Davies RW,Wells GA,Stewart AF,et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex[J]. Circ Cardiovasc Genet,2012,5(2):217-225.
[13] Xie F,Chen Z,Ding Z,et al. A novel major histocompatibility complex locus confers the risk of premature coronary artery disease in a Chinese Han population[J]. Mol Biol Rep,2013,40(5):3649-3654.
[14] Posadas-Sánchez R,Angeles-Martínez J,Pérez-Hernández N,et al. The IL-10-1082 (rs1800896) G allele is associated with a decreased risk of developing premature coronary artery disease and some IL-10 polymorphisms were associated with clinical and metabolic parameters. The GEA study[J]. Cytokine,2018,106:12-18.
[15] Moschen AR,Tilg H,Raine T. IL-12,IL-23 and IL-17 in IBD:immunobiology and therapeutic targeting[J]. Nat Rev Gastroenterol Hepatol,2019,16(3):185-196.
[16] Vázquez-Vázquez C,Posadas-Sánchez R,Pérez-Hernández N, et al. The rs2066808 polymorphism located near the IL-23A gene is associated with premature coronary artery disease in Mexican population (GEA Study)[J]. DNA Cell Biol,2019,38(8):880-886.
[17] Vázquez-Vázquez C,Posadas-Sánchez R,Fragoso JM,et al. IL-12B polymorphisms are associated with the presence of premature coronary artery disease and with cardiovascular risk factors:the genetics of atherosclerotic disease Mexican study[J]. DNA Cell Biol,2020,39(7):1347-1355.
[18] Brune Z,Rice MR,Barnes BJ. Potential T cell-intrinsic regulatory roles for IRF5 via cytokine modulation in T helper subset differentiation and function[J]. Front Immunol,2020,11:1143.
[19] Posadas-Sánchez R,Cardoso-Salda?a G,Fragoso JM,et al. Interferon regulatory factor 5 (IRF5) gene haplotypes are associated with premature coronary artery disease. Association of the IRF5 polymorphisms with cardiometabolic parameters. The genetics of atherosclerotic disease (GEA) Mexican study[J]. Biomolecules,2021,11(3):443.
[20] Wang F,Wang IZ,Ellis S,et al. Analysis of causal effect of APOA5 variants on premature coronary artery disease[J]. Ann Hum Genet,2018,82(6):437-447.
[21] You Y,Wu YH,Zhang Y,et al. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin,northeast China:a case-control study[J]. BMJ Open,2018,8(6):e020016.
[22] Marais AD. Apolipoprotein E in lipoprotein metabolism,health and cardiovascular disease[J]. Pathology,2019,51(2):165-176.
[23] Zhao QR,Lei YY,Li J,et al. Association between apolipoprotein E polymorphisms and premature coronary artery disease:a meta-analysis[J]. Clin Chem Lab Med,2017,55(2):284-298.
[24] Xu S,Cheng J,Li NH,et al. The association of APOC4 polymorphisms with premature coronary artery disease in a Chinese Han population[J]. Lipids Health Dis,2015,14:63.
[25] Du Y,Chen K,Liu E,et al. Gender-specific associations of CD36 polymorphisms with the lipid profile and susceptibility to premature multi-vessel coronary artery heart disease in the Northern Han Chinese[J]. Gene,2020,753:144806.
[26] Sillen M,Declerck PJ. Thrombin activatable fibrinolysis inhibitor (TAFI):an updated narrative review[J]. Int J Mol Sci,2021,22(7):3670.
[27] Rattanawan C,Komanasin N,Settasatian N,et al. Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease[J]. Thromb Res,2018,171:171-176.
[28] Li C,Ren H,Chen H,et al. Prothrombin G20210A (rs1799963) polymorphism increases myocardial infarction risk in an age-related manner:a systematic review and meta-analysis[J]. Sci Rep,2017,7(1):13550.
[29] Xu DL,Tian HL,Cai WL,et al. Novel 6-bp deletion in MEF2A linked to premature coronary artery disease in a large Chinese family[J]. Mol Med Rep,2016,14(1):649-654.
[30] Pérez-Hernández N,Posadas-Sánchez R,Vargas-Alarcón G,et al. Genetic variants and haplotypes in OPG gene are associated with premature coronary artery disease and traditional cardiovascular risk factors in Mexican population:the GEA study[J]. DNA Cell Biol,2020,39(11):2085-2094.
[31] Coto E,Reguero JR,Avanzas P,et al. Gene variants in the NF-KB pathway (NFKB1,NFKBIA,NFKBIZ) and risk for early-onset coronary artery disease[J]. Immunol Lett,2019,208:39-43.
[32] Wang Y,Wu B,Zhang M,et al. Significant association between rs28362491 polymorphism in NF-κB1 gene and coronary artery disease:a meta-analysis[J]. BMC Cardiovasc Disord,2020,20(1):278.
[33] Ma X,Huang J,Lu D,et al. Genetic variability of the glucose-dependent insulinotropic peptide gene is involved in the premature coronary artery disease in a Chinese population with type 2 diabetes[J]. J Diabetes Res,2018,2018:6820294.
[34] Kiani A,Mohamadi-Nori E,Vaisi-Raygani A,et al. Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases[J]. Mol Biol Rep,2019,46(5):5225-5236.
相似文献/References:
[1]唐欣 罗素新.心房颤动合并 射血分数保留的心力衰竭的研究进展[J].心血管病学进展,2019,(5):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
TANG Xin,LUO Suxin.Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(4):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
[2]黄巧娟 周晓莉.冠状动脉慢血流现象的研究进展[J].心血管病学进展,2020,(2):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
HUANG QiaojuanZHOU Xiaoli.Coronary Slow Flow Phenomenon[J].Advances in Cardiovascular Diseases,2020,(4):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
[3]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(4):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[4]郭辅定 殷铭 赖燕秋 江洪.蒽环类药物相关心血管疾病与自主神经调控展望[J].心血管病学进展,2021,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
GUO Fuding,YIN Ming,LAI Yanqiu,et al.Anthracycline-induced Cardiovascular Diseases and Autonomic Nervous Regulation[J].Advances in Cardiovascular Diseases,2021,(4):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
[5]韩雅洁 范小倩 巩彩霞 赵子龙 乔成栋.致心律失常性左室心肌病的研究进展[J].心血管病学进展,2021,(4):342.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.013]
HAN Yajie,FAN Xiaoqian,GONG Caixia,et al.Arrhythmogenic Left Ventricular Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(4):342.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.013]
[6]韩嘉明 高中山 马玉兰.不适当窦性心动过速的研究进展[J].心血管病学进展,2022,(3):253.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
HAN JiamingGAO ZhongshanMA Yulan.Inappropriate Sinus Tachycardia[J].Advances in Cardiovascular Diseases,2022,(4):253.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
[7]聂琼 吴镜.射血分数保留性心力衰竭：从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(4):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[8]智慧 赵青 柳志红.慢性血栓栓塞性肺动脉高压发病机制新进展：从基础到临床[J].心血管病学进展,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
HUANG Zhihua,LUO Qin,ZHAO Zhihui,et al.Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension:from Bench to Bedside[J].Advances in Cardiovascular Diseases,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
[9]丁晓彤 郭俊 王大震 朱胜松 杨斐然 唐闽.肾积水与高血压的研究进展[J].心血管病学进展,2023,(3):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
DING Xiaotong,GUO Jun,WANG Dazhen,et al.Hydronephrosis and Hypertension[J].Advances in Cardiovascular Diseases,2023,(4):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
[10]张丹 钟广伟 杨海燕 时拥月 秦钦 姚佳梅.左心室心肌致密化不全心肌病的研究进展[J].心血管病学进展,2023,(4):316.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
ZHANG DanZHONG Guangwei,YANG Haiyan,SHI Yongyue,et al.Left Ventricular Noncompaction Cardiomyopathy[J].Advances in Cardiovascular Diseases,2023,(4):316.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]